| Description | Established from the pituitary tumor of an ovarectomized F344 rat treated with estrogen for 3 months; described as showing markedly reduced levels of TGF-β1 and TGF-β type II receptor mRNA; reported as being resistant to antiproliferative effects of TGF-β |